Chief
Editor Past
issues
|
Meet the Team BIOGRAPHY
Jeffery L. Cummings MD, Jeffrey
L. Cummings, M.D. was born in Wyoming.
He graduated from the University of Wyoming with high honors
and attended medical school at the University of Washington in Seattle.
Following medical school, Dr. Cummings completed a rotating internship
at Hartford Hospital (a Yale affiliate) in Hartford, Connecticut.
After internship, he went to Boston University in Boston, Massachusetts
for his Neurology residency and Fellowship in Behavioral Neurology.
Fellowship training in the United States was followed by a Research
Fellowship in Neuropathology and Neuropsychiatry at the National Hospital
for Nervous Diseases, Queen Square, London, England.
Dr. Cummings joined the UCLA faculty in 1980 and progressed to
the rank of Professor in 1990. In 1996 he was made The Augustus S. Rose Professor of Neurology.
He is also Professor of Psychiatry and Biobehavioral Sciences
at UCLA.
His
current titles include: Professor Hervé ALLAIN, MD, Rennes University, Rennes, FRANCE Hervé
Allain was born in St Brieuc (France) in 1950, married in 1973 (4 children)
and obtained his degrees of medecine and physiology at the University
of Rennes I (France). His training and diploma in Pharmacology were
obtained in Paris after several stays abroad in clinical pharmacology
(Rochester NY, USA ; Berlin, Germany ; Bombay, India ; Stockholm, Sweden).
He was professor of Medecine in 1982 specialized both in Neurology and
Pharmacology. He obtained the direction of the Department of Experimental
and Clinical Pharmacology in 1992 at the Rennes Medical School. His
main involvement in scientific research deals with central nervous system
(CNS) pharmacology including psychotropics and compounds specifically
used in Neurology. He published 500 papers and book chapters ; 175 references
appear on Medline (Pubmed). The frontiers between psychiatry and neurology
are particularly studied in his department with a clear focus on cognitive
functions and their modulation by CNS drugs. The gap between neurosciences
(ie : neurotransmitters and their receptors) and efficacy or side-effects
in humans represents a deal for his team. H. Allain teaches at different
levels of pharmacy and medicine in Rennes University ; he created 7
years ago a teaching course on the web :
www.med.univ-rennes1.fr/etud/pharmaco. The main involvement at the present time, is the participation in the discovery in new compounds in the treatment of Alzheimer's Disease and other Dementia. Involvement in regulatory affairs and Drug Agencies (AFFSaPS, EMEA) is part on the activities. |
July
2004 A
study on physical, social and mental problems of the elderly in District
13 of Tehran Active
Aging: the whole society benefits
|